Artichoke extract is a herbal supplement derived from globe artichoke leaves, traditionally used for digestive complaints. Some people consider it for fatty liver disease due to laboratory studies suggesting antioxidant and bile-stimulating properties. However, there is no established clinical evidence or UK regulatory approval linking artichoke extract to the treatment of fatty liver disease. The MHRA, NICE, and EMA have not endorsed this use. This article examines what artichoke extract is, the evidence surrounding its use in fatty liver disease, and the proven lifestyle modifications and medical treatments recommended by UK clinical guidelines.

What Is Artichoke Extract and How Does It Work?

Artichoke extract is a herbal supplement derived from the leaves of Cynara scolymus, commonly known as globe artichoke. This plant has been used in traditional medicine for centuries, particularly for digestive complaints. The extract contains several bioactive compounds, with cynarin and luteolin being the most studied constituents.

Laboratory studies suggest that artichoke leaf extract may have antioxidant and anti-inflammatory properties. Some research indicates that cynarin may stimulate bile flow (a choleretic effect) and that the extract might influence lipid metabolism. However, these mechanisms have been studied primarily in laboratory and animal models, and their relevance to human fatty liver disease remains uncertain.

It is crucial to understand that there is no established clinical evidence or regulatory approval linking artichoke extract to the treatment of fatty liver disease. The MHRA, NICE, and EMA have not endorsed artichoke extract for this indication. Most evidence comes from small-scale studies that are insufficient to draw definitive clinical conclusions.

In the UK, some artichoke leaf products hold MHRA Traditional Herbal Registration (THR) for the short-term relief of symptoms related to indigestion and mild digestive discomfort, based on traditional use. However, no artichoke product is licensed or registered for the treatment of fatty liver disease. The extract is classified as a food supplement or traditional herbal medicine rather than a licensed medicine, meaning it has not undergone the rigorous testing required for pharmaceutical products used to treat liver conditions.

Patients considering artichoke extract should be aware that supplements and traditional herbal medicines vary in quality and potency between products. Always consult your GP or a registered healthcare professional before starting any supplement, particularly if you have existing liver disease or are taking other medications. Artichoke extract should not replace evidence-based lifestyle modifications or medical treatment for fatty liver disease.

Understanding Fatty Liver Disease: Causes and Symptoms

Fatty liver disease, medically termed hepatic steatosis, occurs when excess fat accumulates in liver cells. There are two main types: non-alcoholic fatty liver disease (NAFLD), which affects people who drink little or no alcohol, and alcohol-related liver disease (ARLD), in which fatty change is an early stage. NAFLD is increasingly common in the UK, affecting approximately one in three adults, and is closely associated with obesity, type 2 diabetes, and metabolic syndrome.

The primary causes of NAFLD include:

• Insulin resistance – reduced cellular response to insulin leads to increased fat storage in the liver

• Obesity – particularly central (abdominal) obesity

• Type 2 diabetes and prediabetes

• High cholesterol and triglycerides

• Metabolic syndrome – a cluster of conditions including high blood pressure, elevated blood sugar, and abnormal cholesterol levels

In most cases, fatty liver disease produces no symptoms in its early stages, which is why it is often discovered incidentally during blood tests or imaging for other conditions. When symptoms do occur, they may include persistent fatigue, discomfort in the upper right abdomen, and general malaise. However, these symptoms are non-specific and can be attributed to many conditions.

The condition exists on a spectrum. Simple fatty liver (steatosis) is generally benign, but in some individuals it can progress to non-alcoholic steatohepatitis (NASH), where inflammation and liver cell damage occur. NASH can further advance to fibrosis (scarring), cirrhosis, and in rare cases, liver cancer. Risk factors for progression include older age, diabetes, obesity, and certain genetic factors.

Diagnosis typically involves blood tests (liver function tests) and imaging such as ultrasound. However, liver function tests can be normal in NAFLD, and ultrasound has limited sensitivity for detecting early disease. In the UK, risk stratification using non-invasive fibrosis scores is recommended. NICE guidance suggests calculating the FIB-4 score or NAFLD Fibrosis Score in adults with suspected or incidental NAFLD. If the score is indeterminate or suggests advanced fibrosis, an Enhanced Liver Fibrosis (ELF) blood test should be performed. An ELF score of 10.51 or above indicates probable advanced fibrosis and warrants referral to hepatology services. Retesting with ELF approximately every three years may be considered in adults with lower scores to monitor disease progression.

NICE does not recommend routine population screening for NAFLD. Instead, a case-finding approach is used when fatty liver is suspected or discovered incidentally, particularly in people with type 2 diabetes, obesity, or metabolic syndrome.

How to Use Artichoke Extract Safely

If you are considering artichoke extract as a complementary approach, safety should be your primary concern. Artichoke extract is available in various forms including capsules, tablets, and liquid tinctures. Doses vary widely between products depending on the standardisation and concentration of active constituents. There is no officially recommended therapeutic dose for liver conditions, and no clinical evidence supports its use in fatty liver disease. Always follow the manufacturer's instructions on the product label.

Before starting artichoke extract, consult your GP or a registered healthcare professional, particularly if you:

• Have been diagnosed with liver disease or abnormal liver function tests

• Are taking prescription medications (a pharmacist or GP can check for potential interactions)

• Have gallstones or bile duct obstruction (artichoke extract may stimulate bile production and could potentially trigger biliary colic)

• Are pregnant or breastfeeding (safety data are insufficient)

• Have known allergies to plants in the Asteraceae (Compositae) family, including ragweed, chrysanthemums, marigolds, or daisies

When choosing a product, look for those with MHRA Traditional Herbal Registration (THR), which indicates the product meets UK quality and safety standards for its registered indication (typically indigestion). However, remember that no artichoke product is registered or licensed for the treatment of fatty liver disease.

Common side effects are generally mild and may include flatulence, nausea, and loose stools, particularly when first starting the supplement. These effects often resolve as your body adjusts. Discontinue use and seek medical advice if you experience severe abdominal pain, jaundice (yellowing of skin or eyes), dark urine, or signs of an allergic reaction such as rash, itching, or difficulty breathing.

If you experience any suspected side effects from artichoke extract or any other herbal product, you can report them via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or through the Yellow Card app. This helps improve the safety monitoring of herbal medicines and supplements.

It is essential to understand that artichoke extract should not replace evidence-based lifestyle modifications or medical treatment recommended by your healthcare team. Regular monitoring of liver health through blood tests and risk stratification is advisable if you have fatty liver disease, regardless of whether you use supplements. Inform all healthcare professionals involved in your care about any supplements you are taking, as they may interact with prescribed medications or affect interpretation of blood test results.

Other Evidence-Based Treatments for Fatty Liver Disease

The cornerstone of managing fatty liver disease, particularly NAFLD, is lifestyle modification, which has the strongest evidence base for improving liver health and preventing disease progression. NICE guidelines emphasise that there are currently no licensed pharmacological treatments specifically for NAFLD, making lifestyle interventions the primary therapeutic approach.

Weight loss is the most effective intervention for NAFLD. Studies demonstrate that losing 7–10% of body weight can significantly reduce liver fat, inflammation, and even fibrosis. This should be achieved gradually through:

• Dietary modification – adopting a Mediterranean-style diet rich in vegetables, fruits, whole grains, legumes, nuts, and olive oil, whilst limiting processed foods, refined carbohydrates, and saturated fats

• Calorie reduction – creating a modest energy deficit (typically around 600 kcal per day, in line with NICE obesity guidance)

• Limiting sugar intake – particularly fructose from sugary drinks and processed foods

• Reducing alcohol consumption – UK guidance recommends not regularly drinking more than 14 units of alcohol per week, spread over three or more days. In people with advanced liver disease, abstinence may be advised

Regular physical activity is equally important. The UK Chief Medical Officers recommend at least 150 minutes of moderate-intensity aerobic exercise weekly (such as brisk walking, cycling, or swimming) plus muscle-strengthening activities on two or more days per week. Exercise improves insulin sensitivity and reduces liver fat independently of weight loss.

For patients with type 2 diabetes and NAFLD, optimising blood glucose control is crucial. Certain diabetes medications, particularly pioglitazone and GLP-1 receptor agonists (such as liraglutide), have shown benefits in reducing liver fat and inflammation in clinical trials, though they are not specifically licensed for this indication. Treatment decisions should be made by your GP or diabetes specialist.

Management of associated conditions is essential:

• Statins for dyslipidaemia (high cholesterol) – these are safe to use in people with NAFLD and provide important cardiovascular risk reduction

• Blood pressure control – using appropriate antihypertensive medications as advised by your GP

• Vitamin E supplementation – may be considered only in adults with biopsy-proven NASH without diabetes, and should only be initiated under specialist hepatology supervision

Regular monitoring using the UK risk-stratification pathway is important. Your GP may calculate your FIB-4 score or NAFLD Fibrosis Score. If the result is indeterminate or suggests advanced fibrosis, an Enhanced Liver Fibrosis (ELF) blood test will be arranged. An ELF score of 10.51 or above indicates probable advanced fibrosis and you will be referred to hepatology services. Retesting with ELF approximately every three years may be considered in adults with lower scores.

Contact your GP urgently if you experience unexplained weight loss, persistent abdominal pain or swelling, jaundice (yellowing of skin or eyes), dark urine, pale stools, ankle swelling, confusion, or vomiting blood, as these may indicate liver disease progression or complications requiring urgent assessment. Regular monitoring through blood tests, risk scores, and specialist review when indicated helps track disease progression and treatment response.

Frequently Asked Questions